The Pros and Cons of Standardized Testing
Is Your Testing Program Ready for the EU MDRs?
Another Reason to Update Your Biocompatibility Approach: EU MDRs
SyncThink Goes for Magic Leap to Get into AR
ArcherDx Seeking Broader Reach for Cancer Diagnostic
New Study Finds Discrepancies in Cervical Cancer Screening Rates
Veracyte Finds Ally in J&J for Early Lung Cancer Detection
Consider the Most Probable Number Method for Bioburden Testing
7 Key Events That Solidified the Liquid Biopsy Market